5 withdrawn. 5 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Withdrawn 5 |
| Phase 1 | 1 | Withdrawn 1 |
Follow Osteosarcoma: new trials by email Literature Review of Osteosarcoma trials Research Report on Osteosarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Pilot Study of Thermodox and MR-HIFU for Treatment of Relapsed Solid Tumors Magnetic Resonance-Guided High Intensity Focused Ultrasound, Lyso-thermosensitive Liposomal Doxorubicin - Solid Tumors, Soft Tissue Sarcoma | Phase 2 | Withdrawn | Children's National Research Institute | 2022-11-10 | 2025-01-01 | |
| Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma Gemcitabine, 9-ING-41, Docetaxel - Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma | Phase 2 | Withdrawn | Brown University | 2022-03-01 | 2021-12-07 | |
| Lurbinectedin With or Without Irinotecan in Treating Patients With Relapsed or High Risk Metastatic Ewing Sarcoma Fine-Needle Aspiration, Irinotecan, Irinotecan Hydrochloride - Metastatic Ewing Sarcoma, Recurrent Ewing Sarcoma | Phase 1 / Phase 2 | Withdrawn | M.D. Anderson Cancer Center | 2021-09-15 | 2022-02-10 | |
| Erlotinib in Combination With Temozolomide in Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors Erlotinib, Temozolomide - Glioma, Rhabdomyosarcoma | Phase 2 | Withdrawn | Washington University School of Medicine | 2016-08-06 | 2019-09-09 | |
| Imetelstat Sodium in Treating Younger Patients With Relapsed or Refractory Solid Tumors Imetelstat Sodium, Laboratory Biomarker Analysis - Hepatoblastoma, Previously Treated Childhood Rhabdomyosarcoma | Phase 2 | Withdrawn | Children's Oncology Group | 2014-06-30 | 2018-08-07 |
Rhabdomyosarcoma (4) · Sarcoma, Ewing (3) · Sarcoma (2) · Wilms Tumor (2) · Bone Neoplasms (1) · Carcinoma (1) · Carcinoma, Hepatocellular (1) · Dermatofibrosarcoma (1) · Ependymoma (1) · Glioma (1) · Hemangiosarcoma (1) · Hepatoblastoma (1) · Histiocytoma, Malignant Fibrous (1) · Leiomyosarcoma (1)
Neoplasms (5) · Neoplasms by Histologic Type (5) · Neoplasms, Bone Tissue (5) · Neoplasms, Connective Tissue (5) · Neoplasms, Connective and Soft Tissue (5) · Myosarcoma (4) · Neoplasms, Muscle Tissue (4) · Neoplasms by Site (3) · Neoplasms, Complex and Mixed (3) · Neoplasms, Glandular and Epithelial (3) · Sarcoma (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genetic Diseases, Inborn (2)
3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione (1) · Biopsy, Fine-Needle (1) · Docetaxel (1) · Erlotinib Hydrochloride (1) · GRN163L peptide (1) · Gemcitabine (1) · Irinotecan (1) · PM 01183 (1) · Temozolomide (1) · imetelstat (1)
Brown University (1) · Children's National Research Institute (1) · Children's Oncology Group (1) · M.D. Anderson Cancer Center (1) · Washington University School of Medicine (1)
United States (3)
AeRang Kim, MD, PhD (1) · Alok Kothari, M.D. (1) · Bradley D DeNardo, MD (1) · Galina G Lagos, MD (1) · Patrick Thompson (1) · Robert S Benjamin (1)
U10CA098543 (1)